Usefullness of thoracic MRI in the management of lung cancer -comparison with FDG-PET-

Usefullness of thoracic MRI in the management of lung cancer -comparison with FDG-PET- - Usefullness of thoracic MRI in the management of lung cancer -comparison with FDG-PET-

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005197

Enrollment

Registered

2011-03-07

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

MRI examination FDG-PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients suspected of lung cancer on CT examination

Exclusion criteria

Exclusion criteria: patients with hyperglycemia (over 150mg/dl of fasting blood sugar level) patients with metalic device in their body

Design outcomes

Primary

Measure	Time frame
Diagonis-diagnostic accuracy based on pathological results. Evaluation of herapeutic effect-relationship between the degree of response and progression-free survival	—

Countries

Japan

Contacts

Public ContactTatsuro Tsuchida

University of Fukui Hospital Department of Radiology

tsucchy@u-fukui.ac.jp0776-61-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026